WallStSmart
IONS

Ionis Pharmaceuticals Inc

NASDAQ: IONS · HEALTHCARE · BIOTECHNOLOGY

$74.76
-0.09% today

Updated 2026-04-30

Market cap
$11.85B
P/E ratio
P/S ratio
12.56x
EPS (TTM)
$-2.38
Dividend yield
52W range
$30 – $87
Volume
2.2M

Ionis Pharmaceuticals Inc (IONS) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-53.23M$36.09M$212.03M$-108.44M$-63.59M$-114.80M$1.88M$63.49M$6.29M$21.13M$-112.11M$174.15M$602.89M$345.72M$35.89M$30.80M$-274.37M$-307.51M$-500.95M$-268.58M
Capital expenditures$2.56M$5.01M$17.07M$16.29M$17.56M$11.00M$5.17M$5.36M$11.10M$11.75M$11.53M$37.86M$17.65M$36.28M$41.05M$17.90M$20.10M$28.01M$45.28M$51.44M
Depreciation
Stock-based comp$5.75M$9.91M$15.06M$13.38M$12.16M$9.85M$8.57M$11.42M$31.38M$59.31M$72.11M$85.97M$131.31M$146.57M$230.12M$120.68M$100.26M$105.81M$130.20M$133.87M
Free cash flow$-55.78M$31.08M$194.96M$-124.73M$-81.15M$-125.80M$-3.29M$58.13M$-4.82M$9.38M$-123.63M$136.29M$585.24M$309.44M$-5.16M$12.90M$-294.47M$-335.52M$-546.23M$-320.03M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$165.61M$16.73M$10.95M
Share repurchases
Debt repayment
Net change in cash$-35.20M$-4.58M$59.01M$35.49M$-16.98M$-14.20M$-44.11M$44.95M$149.19M$404.47M$-285.62M$471.53M$-592.30M